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Proteolytic processing of amyloid precursor protein (APP)
by b-site APP cleaving enzyme 1 (BACE1) and g-secretase
generates Ab peptides. APP is constitutively trafficked
through the secretory and endocytic pathways in cultured
cells and neurons. The identities of cellular organelles and
sorting pathways involved in amyloidogenic processing of
APP have been extensively investigated. Although a con-
sensus has not yet emerged, there is a general agreement
from biochemical and genetic studies on the importance
of endocytic APP trafficking for Ab production. In neu-
rons, APP is trafficked anterogradely along peripheral and
central axons, and proteolytically processed during transit.
Recent in vivo studies estimated that ~70% of Ab released
in the brain requires ongoing endocytosis, and synaptic
activity regulates the vast majority of this endocytosis-
dependent Ab. BACE1 cleavage is thought to be the rate-
limiting step in amyloidogenic processing of APP. Little,
however, is known about endocytic BACE1 sorting and
dynamic transport in neurons. We investigated BACE1
trafficking in cultured hippocampal neurons using live-cell
imaging and selective labeling. This approach revealed
dynamic neuronal transport of internalized BACE1 in den-
drites and axons. BACE1 was transported in vesicles that
were positive for markers of recycling endosomes. Domi-
nant-negative expression and siRNA knock-down of pro-
teins involved in endocytic transit revealed that BACE1 is
dynamically transported in recycling endosomes and this
process significantly contributes to amyloidogenic APP
processing. Our results suggest that BACE1 trafficking in
neuronal recycling endosomes is likely relevant for presy-
naptic Ab production and contributes to Alzheimer’s
disease pathogenesis.
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